Y. Tomiyama et al., A GLANZMANN THROMBASTHENIA-LIKE PHENOTYPE CAUSED BY A DEFECT IN INSIDE-OUT SIGNALING THROUGH THE INTEGRIN ALPHA(IIB)BETA(3), Thrombosis and haemostasis, 80(5), 1998, pp. 735-742
Activation of the platelet integrin alpha(IIb)beta(3), an essential st
ep in platelet aggregation, is regulated by intracellular signal pathw
ays (inside-out signaling). In this study, we characterize a 35-year-o
ld Japanese female, HM, with a life-long history of mucocutaneous blee
ding. HM showed a Glanzmann thrombasthenia-like phenotype with normal
expression of alpha(IIb)beta(3), and failure of platelet aggregation i
nduced by various agonists. An activation-independent ligand mimic mon
oclonal antibody (mAb), OP-G2, and RODS peptides bound normally to the
patient's alpha(IIb)beta(3),, while an activating anti-beta(3) mAb, A
P5, induced normal aggregation of HM platelets. The nucleotide sequenc
e of the entire coding region of the patient's alpha(IIb) and beta(3),
including the cytoplasmic domains of each subunit, revealed no abnorm
alities. Agonist-induced phosphorylation of platelet pleckstrin and my
osin light chain was not impaired. Recently, we proposed that a Na+/Ca
2+ exchanger is involved in inside-out signaling, especially in the ca
se of chymotrypsin-induced alpha(IIb)beta(3) activation (Blood 88: 259
4, 1996). However, chymotrypsin-induced platelet aggregation occurred
normally in patient HM. Measurement of changes in cytosolic free calci
um concentration ([Ca2+](i)) revealed that the plateau level of [Ca2+]
(i) after thrombin stimulation was significantly inhibited in patient
HM. Our data suggest that patient HM exhibits a Glanzmann thrombasthen
ia-like phenotype associated with an abnormality in inside-out signali
ng which would otherwise activate alpha(IIb)beta(3).